Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 33 separate institutions with over 107 different research grants totaling over $150 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
2009
THE IVY GBM ATLAS PROJECT: ANATOMIC GENE EXPRESSION ATLAS OF HUMAN GLIOBLASTOMA
PIs: Ralph B. Puchalski, Ph.D.
Research Alliance Manager
Allen Institute for Brain Science
Greg Foltz, M.D.
Director, Center for Advanced Brain Tumor Treatment
Swedish Neuroscience Institute
IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM
PI: Michael D. Prados, M.D.
Charles B. Wilson Professor of Neurosurgergery
Professor of Pediatrics (Neuro-Oncology)
Program Leader, Neurological Oncology Program, UCSF Helen Diller Cancer Center
Project Leader, Ivy Foundation Early Phase Clinical Trials Consortium
Project Leader, Pacific Pediatric Neuro-Oncology Consortium
University of California San Francisco (UCSF)
18F PPRGD2 PET/CT, 18F FDG PET/CT AND MRI EVALUATION OF RESPONSE TO ANTI-ANGIOGENESIS THERAPY IN RECURRENT GLIOBLASTOMA MULTIFORME
PIs: Sanjiv Sam Gambhir, M.D., Ph.D.
Head of Radiology and Nuclear Medicine Program
Stanford University
Andrei H. Iagaru, M.D., F.A.C.N.M.
Associate Professor of Radiology
Co-Chief, Nuclear Medicine
Co-Director, Division of Nuclear Medicine and Molecular Imaging
Director, PET-MRI Research Program
Nuclear Medicine Residency Program
Stanford University Medical Center
USING GENOMIC SIGNATURES TO PREDICT COMBINATION THERAPY IN GBM
PIs: John H. Sampson, M.D., Ph.D., M.H.Sc.
Associate Professor of Surgery
Associate Deputy Director
Preston Robert Tisch Brain Tumor Center at Duke
Joseph R. Nevins, Ph.D.
Barbara Levine Professor of Cancer Genomics
Director Center for Applied Genomics & Technology
Duke Institute for Genome Sciences & Policy
SYSTEMATIC FUNCTIONAL INTERROGATION OF THE GBM GENOME FOR CURATIVE COMBINATION THERAPY
PIs: Ronald A. DePinho, M.D.
Director, Belfer Institute for Applied Cancer Science
Dana-Farber Cancer Institute
Lynda Chin, M.D.
Professor of Dermatology
Harvard Medical School
Dana-Farber Cancer Institute